We hold pharmaceutical companies responsible for opioid-induced illness.

Opioids

Holding opioid manufacturers and distributors responsible for harm to unsuspecting patients and parents

Waters Kraus & Paul has been representing people injured by dangerous products and prescription drugs for over 20 years. For example, it is the only plaintiffs’ firm to obtain a verdict against the pharmaceutical manufacturer in a PPA (phenlypropanolamine)/stroke case. Our firm has now turned its sights on irresponsible manufacturers and distributors of opioids like OxyContin, Norco, Vicodin, and Fentanyl because those manufacturers and distributors mislead the public and regulators about the proper use and hazards of those highly-addictive drugs, all in the name of profits.

Made from the poppy plant or synthesized in the lab, opioids are a wide-ranging group of pain management medications that are highly addictive. Therefore, the medical standard of care had been to limit their use to patients with acute or traumatic injuries, or to patients with terminal cancer. That ended when the manufacturers, realizing that there was a huge untapped market in patients with long-term, chronic pain, launched a misleading campaign to convince doctors and regulators that those highly-addictive drugs were safe and effective for long-term use. Articles backed by the drug makers and published in medical journals as well as pharmaceutical commercials pushed the drugs as effective over the long-term—something that has not been proved to this day— while downplaying the dangerous side effects, including addiction, overdose, and death. Complicating matters further, most primary care providers have not been trained to identify addiction or withdrawal symptoms, and have been hoodwinked by industry-sponsored “medical” articles counseling them that patients who appear to be addicted are actually suffering from “pseudoaddiction,” the remedy for which is a higher dose of opioids!

That misleading marketing campaign continues to this day, and has caused an opioid epidemic unparalleled in U.S. history, an epidemic that is not only responsible for a tide of addiction, but for a documented decrease in American life spans. That epidemic is also straining public services, damaging local economies, and harming whole families.

Women who become pregnant while taking opioid medication will often remain on opioids through a maintenance therapy program for the duration of pregnancy, never warned that this opioid regimen can harm their baby. As a result, the babies are born sedated and addicted, a condition known as (Neonatal Abstinence Syndrome, or “NAS”). Hospitals have seen an increase in NAS babies, whose treatment is painful for the babies as they go through monitored withdrawal in the hospital, and expensive for the hospital, families, and public/private insurance carriers.

Opioid use while pregnant may also cause birth defects. Treatment of pregnant women with opioid medications is linked to specific birth defects including spina bifida, hydrocephaly, glaucoma, gastroschisis, and congenital heart defects.

How Waters Kraus & Paul can help

At Waters Kraus & Paul we have seen first-hand the heartbreak and financial challenges of families facing catastrophic prescription drug injury. We have represented families with children suffering from birth defects linked to popular prescription antidepressants and children who have endured life-threatening skin diseases resulting from antibiotics and NSAIDs. With a national presence and a wealth of experience, our firm has the resources to bring your case in any court in the country. To have one of our attorneys review your potential opioid case and file a claim, email us or call 800.226.9880.

Opioids and Opiates

  • Oxycodone
    • Endocet
    • Oxecta
    • OxyContin
    • Percocet
    • Roxicet
    • Roxicodone
    • Targiniq ER
  • Oxymorphone
    • Opana
  • Fentanyl
    • Actiq
    • Duragesic
  • Fentora
  • Subsys
  • Hydrocodone
    • Hysingla ER
    • Lorcet
    • Norco
    • Vicodin
    • Zohydro ER
  • Meperidine
    • Demero
  • Buprenorphine
    • Suboxone
    • Butrans
    • Subutex

Xarelto vs. Aspirin…The Outcome May Shock You

January 2, 2018 According to a study, prescription Xarelto® shows no superiority compared to over-the-counter aspirin. Bayer and Johnson & Johnson’s Janssen Research & Development have acknowledged that their Xarelto® (rivaroxaban) has failed a Phase III trial assessing the anticoagulant in patients with…

Xarelto Dangers Investigated in Canada

October 12, 2015 The Canadian government has recently initiated a probe into the dangers associated with the blood thinner Xarelto (rivaroxaban). In July 2011, the U.S. Food & Drug Administration (FDA) approved the anti-clotting agent for patients receiving knee and hip replacements, to…

Gary Paul, Michael Armitage & Scott Frost Named on 2018 Southern California Super Lawyers List

February 13, 2018 Waters Kraus & Paul partners selected to appear in 2018 Southern California Super Lawyers Magazine Gary Paul, Michael Armitage, and Scott Frost, partners at Waters Kraus & Paul, have each respectively been selected for in inclusion in the 2018 Southern California Super Lawyers list as featured in special sections of The New York Times and The Los Angeles Magazine. This is a special honor in that the list is comprised of only five percent of attorneys in Southern California. About Southern California Super Lawyers Super Lawyers® is a publication of Thompson Reuters and uses a patented multi-phase process to recognize…

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880